Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
8.53M
-
Shares change
-
-247K
-
Total reported value, excl. options
-
$134M
-
Value change
-
-$11.6M
-
Number of buys
-
24
-
Number of sells
-
-14
-
Price
-
$15.74
Significant Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q1 2021
54 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q1 2021.
Protara Therapeutics, Inc. - Common Stock (TARA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.53M shares
of 38.5M outstanding shares and own 22.17% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.56M shares), Rock Springs Capital Management LP (690K shares), Ikarian Capital, LLC (650K shares), VANGUARD GROUP INC (457K shares), ORBIMED ADVISORS LLC (450K shares), PERCEPTIVE ADVISORS LLC (422K shares), Artisan Partners Limited Partnership (380K shares), FRANKLIN RESOURCES INC (350K shares), Cormorant Asset Management, LP (350K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (319K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.